Filing Details
- Accession Number:
- 0001209191-21-042115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 17:07:54
- Reporting Period:
- 2021-06-17
- Accepted Time:
- 2021-06-21 17:07:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770787 | 10X Genomics Inc. | TXG | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189140 | R John Stuelpnagel | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2021-06-17 | 100 | $190.97 | 406,516 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 100 | $191.97 | 406,416 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 200 | $195.30 | 406,216 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 400 | $196.75 | 405,816 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 500 | $197.75 | 405,316 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 600 | $199.30 | 404,716 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 1,700 | $200.23 | 403,016 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 1,000 | $201.03 | 402,016 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 300 | $202.18 | 401,716 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-06-17 | 100 | $203.42 | 401,616 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $194.99 to $195.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $196.36 to $197.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $197.48 to $198.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $198.72 to $199.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $199.725 to $200.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $200.74 to $201.32. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $201.825 to $202.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.